Blennow K - Search Results

1

Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers.

Iqbal K, Flory M, Khatoon S, Soininen H, Pirttila T, Lehtovirta M, Alafuzoff I, Blennow K, Andreasen N, Vanmechelen E, Grundke-Iqbal I. Iqbal K, et al. Among authors: blennow k. Ann Neurol. 2005 Nov;58(5):748-57. doi: 10.1002/ana.20639. Ann Neurol. 2005. PMID: 16247771

2

Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'.

Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Karlsson I, Månsson JE, Svennerholm L. Blennow K, et al. Arch Neurol. 1991 Oct;48(10):1032-5. doi: 10.1001/archneur.1991.00530220048018. Arch Neurol. 1991. PMID: 1929894

3

Altered blood-brain-barrier function in Alzheimer's disease?

Mattila KM, Pirttilä T, Blennow K, Wallin A, Viitanen M, Frey H. Mattila KM, et al. Among authors: blennow k. Acta Neurol Scand. 1994 Mar;89(3):192-8. doi: 10.1111/j.1600-0404.1994.tb01660.x. Acta Neurol Scand. 1994. PMID: 8030400

4

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E. Blennow K, et al. Mol Chem Neuropathol. 1995 Dec;26(3):231-45. doi: 10.1007/BF02815140. Mol Chem Neuropathol. 1995. PMID: 8748926

5

Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele.

Blennow K, Bogdanovic N, Alafuzoff I, Ekman R, Davidsson P. Blennow K, et al. J Neural Transm (Vienna). 1996;103(5):603-18. doi: 10.1007/BF01273157. J Neural Transm (Vienna). 1996. PMID: 8811505

6

A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.

Skoog I, Vanmechelen E, Andreasson LA, Palmertz B, Davidsson P, Hesse C, Blennow K. Skoog I, et al. Among authors: blennow k. Neurodegeneration. 1995 Dec;4(4):433-42. doi: 10.1006/neur.1995.0052. Neurodegeneration. 1995. PMID: 8846237

7

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.

Andreasen N, Vanmechelen E, Van de Voorde A, Davidsson P, Hesse C, Tarvonen S, Räihä I, Sourander L, Winblad B, Blennow K. Andreasen N, et al. Among authors: blennow k. J Neurol Neurosurg Psychiatry. 1998 Mar;64(3):298-305. doi: 10.1136/jnnp.64.3.298. J Neurol Neurosurg Psychiatry. 1998. PMID: 9527138 Free PMC article.

8

Combination of the different biological markers for increasing specificity of in vivo Alzheimer's testing.

Blennow K, Vanmechelen E. Blennow K, et al. J Neural Transm Suppl. 1998;53:223-35. doi: 10.1007/978-3-7091-6467-9_20. J Neural Transm Suppl. 1998. PMID: 9700660 Review.

9

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

Hulstaert F, Blennow K, Ivanoiu A, Schoonderwaldt HC, Riemenschneider M, De Deyn PP, Bancher C, Cras P, Wiltfang J, Mehta PD, Iqbal K, Pottel H, Vanmechelen E, Vanderstichele H. Hulstaert F, et al. Among authors: blennow k. Neurology. 1999 May 12;52(8):1555-62. doi: 10.1212/wnl.52.8.1555. Neurology. 1999. PMID: 10331678

10

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K. Andreasen N, et al. Among authors: blennow k. Arch Neurol. 1999 Jun;56(6):673-80. doi: 10.1001/archneur.56.6.673. Arch Neurol. 1999. PMID: 10369305

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,181 results

Search Page

Filters